[1]Brownetal.[JournaloftheChemicalSociety,1955,p.211,216]
Title: Theoretical study of the regioselectivity of the interaction of 3-methyl-4-pyrimidone and 1-methyl-2-pyrimidone with Lewis acids.
Journal: The journal of physical chemistry. A 20120823
Title: The excited-state decay of 1-methyl-2(1H)-pyrimidinone is an activated process.
Journal: Chemphyschem : a European journal of chemical physics and physical chemistry 20110711
Title: Pharmacophore development and docking studies of the hiv-1 integrase inhibitors derived from N-methylpyrimidones, Dihydroxypyrimidines, and bicyclic pyrimidinones.
Journal: Chemical biology & drug design 20110701
Title: Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects.
Journal: Acta naturae 20110101
Title: Dihydroxy-pyrimidine and N-methylpyrimidone HIV-integrase inhibitors: improving cell based activity by the quaternarization of a chiral center.
Journal: Bioorganic & medicinal chemistry letters 20090815
Title: Raltegravir, elvitegravir, and metoogravir: the birth of 'me-too' HIV-1 integrase inhibitors.
Journal: Retrovirology 20090101
Title: Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors.
Journal: Journal of medicinal chemistry 20080227
Title: 4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species.
Journal: Journal of medicinal chemistry 20061116
Title: HCV NS5b RNA-dependent RNA polymerase inhibitors: from alpha,gamma-diketoacids to 4,5-dihydroxypyrimidine- or 3-methyl-5-hydroxypyrimidinonecarboxylic acids. Design and synthesis.
Journal: Journal of medicinal chemistry 20041021
